Healthcare, Investment

Alibaba Consortium Seeks Privatization Of NASDAQ-listed iKang Healthcare Group

Follow Us:

Chinese healthcare provider iKang Healthcare Group, Inc. (NASDAQ:KANG)announced that a consortium led by Alibaba Investment Limited and Jack Ma co-founded Yunfeng Capital, has proposed a all-cash transaction to privatize the US$1.29 billion company.

The investors proposed to acquire all of the outstanding Class A common shares, Class C common shares, and American depositary shares of the company in an all-cash transaction for US$20.00 per ADS or US$40.00 per share, the company said in a statement.

iKang’s shares closed at US$18.8 yesterday. The firm has 66.89 million shares outstanding.

The company provides healthcare solutions including medical examinations, disease screening and dental service across China. As of March, iKang has a nationwide network of 110 self-owned operating medical centers, in 33 Chinese cities. To extend its coverage is has contracts with over 400 third-party facilities in 200 cities.

In the second quarter ending last September, the company recorded net revenues of US$152.4 million, an increase of 27.3% year-over-year, and net income of US$19.5 million, an increase of 229.0% year-over-year.

Jack Ma has been increasing his investment in healthcare since last year. Alibaba participated in two healthcare investments worth of US$90.25 million. Yunfeng Capital acquired Italian biomedical equipment maker Esaote S.p.A. last December, and led a RMB120 million (US$17 million) series A round in Chinese online drug store last July.

Yunfeng and Alibaba are in discussions with certain significant shareholders regarding their potential support for the iKang proposal.

CMN Bespoke Reports White 728×90

Leave a Reply

Your email address will not be published. Required fields are marked *